Drugs targeting the central nervous system take significantly longer to develop and get approved than other meds, according to a new analysis. In fact, the report cites that CNS drugs took 20% longer to develop and about 19 months (36%) longer on average than other meds to win FDA approval after clinical trials.
Request a Genetics in Clinical Trials training session
What You'll LearnMost Recent Flipbooks
Ideal vs. Reality Budgeting - Create & Negotiate the Best Clinical Trial Budget for Your Site
No Longer an Afterthought - A Call for Greater Diversity and Inclusion in Clinical Trials
